Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-04

Clinical Trial Update: Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas [NA]

View source ↗

Summary

A Phase I study evaluating the safety and feasibility of transarterial embolization for incurable hypervascular pediatric soft tissue sarcomas has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Soft Tissue Sarcomas | NA | Status: WITHDRAWN